Mahmoud E. Soliman

Mahmoud E. Soliman

Auto-generated profile, based on publicly available information

Mahmoud E. Soliman

PharmD Program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, Egypt

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MAMay Abou-ElNour
May Abou-ElNour
MSMahmoud E. Soliman
Mahmoud E. Soliman
ASAthanasios Skouras
Athanasios Skouras
Luca CasettariLuca Casettari
Luca Casettari
AGAhmed S. Geneidi
Ahmed S. Geneidi
RIRania Ishak
Rania Ishak

9 September 2019 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
EEEnas Elmowafy
Enas Elmowafy
Marco CespiMarco Cespi
Marco Cespi
Giulia BonacucinaGiulia Bonacucina
Giulia Bonacucina
MSMahmoud E. Soliman
Mahmoud E. Soliman
The aim of the current investigation is to delineate the buccal applicability of an in situ composite gel containing aceclofenac (AC) amino methacrylate copolymer microparticles (MPs), surmounting limitations of oral existing conventional therapy. AC Eudragit RL100 MPs were fabricated and statistically optimized using 2241 factorial design. Better buccal applicability and enhanced localization were achieved by combining the optimum MPs with in situ ion-activated gellan gum gel. The crosslinking and gelation of in situ gel were investigated by morphological and solid state characterizations. Suitability for buccal delivery and in vivo therapeutic efficacy in inflammation model of rats were also assessed. Results showed that the best performing formula displayed particle size (PS) of 51.00 µm and high entrapment efficiency (EE%) of 94.73%. MPs were successfully entrapped inside the gel network of the composite system. Gelation tendency, pH, shear-thinning properties and mucoadhesivity of the prepared in situ composite gel guaranteed its buccal suitability. Sustained AC release features and promising in vitro anti-arthritic response were also demonstrated. Moreover, consistent and prolonged in vivo anti-inflammatory effect was achieved, relative to standard AC. Taken together; this study proves the potential of in situ composite gel as an appropriate therapeutic proposal for AC buccal delivery.

29 October 2025 in Discover Nano
Verified
Journal Article
Open access
PDF file
MTMuhammad Talaat
Muhammad Talaat
HHHamsa Hassan
Hamsa Hassan
EMEthar Ahmed Mosilhy
Ethar Ahmed Mosilhy
NTNouran A. Taha
Nouran A. Taha
MEMohamed Elsaid
Mohamed Elsaid
MSMahmoud E. Soliman
Mahmoud E. Soliman
Antioxidants showed usefulness in treating or preventing neurodegenerative diseases (NDDs). However, antioxidants have limited bioavailability owing to the